380 related articles for article (PubMed ID: 17184672)
1. Lung volume reduction surgery in patients with emphysema and alpha-1 antitrypsin deficiency.
Stoller JK; Gildea TR; Ries AL; Meli YM; Karafa MT;
Ann Thorac Surg; 2007 Jan; 83(1):241-51. PubMed ID: 17184672
[TBL] [Abstract][Full Text] [Related]
2. Long-term results after lung volume reduction surgery in patients with alpha1-antitrypsin deficiency.
Tutic M; Bloch KE; Lardinois D; Brack T; Russi EW; Weder W
J Thorac Cardiovasc Surg; 2004 Sep; 128(3):408-13. PubMed ID: 15354100
[TBL] [Abstract][Full Text] [Related]
3. Alpha-1 antitrypsin Null mutations and severity of emphysema.
Fregonese L; Stolk J; Frants RR; Veldhuisen B
Respir Med; 2008 Jun; 102(6):876-84. PubMed ID: 18353624
[TBL] [Abstract][Full Text] [Related]
4. Lung-volume reduction surgery as an alternative or bridging procedure to lung transplantation.
Tutic M; Lardinois D; Imfeld S; Korom S; Boehler A; Speich R; Bloch KE; Russi EW; Weder W
Ann Thorac Surg; 2006 Jul; 82(1):208-13; discussion 213. PubMed ID: 16798216
[TBL] [Abstract][Full Text] [Related]
5. Is there a role for therapeutic lobectomy for emphysema?
Vaughan P; Oey I; Nakas A; Martin-Ucar A; Edwards J; Waller D
Eur J Cardiothorac Surg; 2007 Mar; 31(3):486-90; discussion 490. PubMed ID: 17223565
[TBL] [Abstract][Full Text] [Related]
6. Effect of bilateral lung volume reduction surgery on FEV1 decline in severe emphysema.
Travaline JM; Gaughan JP; Furukawa S; Criner GJ
COPD; 2005 Jun; 2(2):203-8. PubMed ID: 17136946
[TBL] [Abstract][Full Text] [Related]
7. A randomized clinical trial of lung volume reduction surgery versus best medical care for patients with advanced emphysema: a two-year study from Canada.
Miller JD; Malthaner RA; Goldsmith CH; Goeree R; Higgins D; Cox PG; Tan L; Road JD;
Ann Thorac Surg; 2006 Jan; 81(1):314-20; discussion 320-1. PubMed ID: 16368389
[TBL] [Abstract][Full Text] [Related]
8. Surgical therapy for chronic obstructive pulmonary disease.
Martinez FJ; Chang A
Semin Respir Crit Care Med; 2005 Apr; 26(2):167-91. PubMed ID: 16088435
[TBL] [Abstract][Full Text] [Related]
9. Two-year improvement in multidimensional body mass index, airflow obstruction, dyspnea, and exercise capacity index after nonresectional lung volume reduction surgery in awake patients.
Pompeo E; Mineo TC
Ann Thorac Surg; 2007 Dec; 84(6):1862-9; discussion 1862-9. PubMed ID: 18036900
[TBL] [Abstract][Full Text] [Related]
10. Functional comparison of unilateral versus bilateral lung volume reduction surgery.
Argenziano M; Thomashow B; Jellen PA; Rose EA; Steinglass KM; Ginsburg ME; Gorenstein LA
Ann Thorac Surg; 1997 Aug; 64(2):321-6; discussion 326-7. PubMed ID: 9262568
[TBL] [Abstract][Full Text] [Related]
11. One- to four-year follow-up of endobronchial lung volume reduction in alpha-1-antitrypsin deficiency patients: a case series.
Hillerdal G; Mindus S
Respiration; 2014; 88(4):320-8. PubMed ID: 25227936
[TBL] [Abstract][Full Text] [Related]
12. Persistent benefit from lung volume reduction surgery in patients with homogeneous emphysema.
Weder W; Tutic M; Lardinois D; Jungraithmayr W; Hillinger S; Russi EW; Bloch KE
Ann Thorac Surg; 2009 Jan; 87(1):229-36; discussion 236-7. PubMed ID: 19101303
[TBL] [Abstract][Full Text] [Related]
13. [Role of surgical lung volume reduction in the treatment of patients with severe emphysema].
Kecskés L; Füredi A
Magy Seb; 2004 Dec; 57(6):370-7. PubMed ID: 15803884
[TBL] [Abstract][Full Text] [Related]
14. [Surgical treatment of severe emphysema: lung transplantation or volume reduction?].
Licker M; de Perrot M; Schweizer A; Tschopp JM; Robert J; Höhn L; Rochat T; Spiliopoulos A
Schweiz Med Wochenschr; 1998 Mar; 128(11):409-15. PubMed ID: 9561587
[TBL] [Abstract][Full Text] [Related]
15. Deficient alpha-1-antitrypsin phenotypes and persistent airflow limitation in severe asthma.
van Veen IH; ten Brinke A; van der Linden AC; Rabe KF; Bel EH
Respir Med; 2006 Sep; 100(9):1534-9. PubMed ID: 16476537
[TBL] [Abstract][Full Text] [Related]
16. Results of lung volume reduction surgery in patients meeting a national emphysema treatment trial high-risk criterion.
Meyers BF; Yusen RD; Guthrie TJ; Patterson GA; Lefrak SS; Davis GE; Cooper JD
J Thorac Cardiovasc Surg; 2004 Mar; 127(3):829-35. PubMed ID: 15001913
[TBL] [Abstract][Full Text] [Related]
17. Evidence-based medicine: lung volume reduction surgery (LVRS).
Koebe HG; Kugler C; Dienemann H
Thorac Cardiovasc Surg; 2002 Oct; 50(5):315-22. PubMed ID: 12375193
[TBL] [Abstract][Full Text] [Related]
18. Duration of air leak is reduced after awake nonresectional lung volume reduction surgery.
Tacconi F; Pompeo E; Mineo TC
Eur J Cardiothorac Surg; 2009 May; 35(5):822-8; discussion 828. PubMed ID: 19233672
[TBL] [Abstract][Full Text] [Related]
19. A review of alpha-1 antitrypsin deficiency.
Ranes J; Stoller JK
Semin Respir Crit Care Med; 2005 Apr; 26(2):154-66. PubMed ID: 16088434
[TBL] [Abstract][Full Text] [Related]
20. [Long-term therapy of alpha 1-antitrypsin-deficiency-associated pulmonary emphysema with human alpha 1-antitrypsin].
Wencker M; Banik N; Buhl R; Seidel R; Konietzko N
Pneumologie; 1998 Oct; 52(10):545-52. PubMed ID: 9847632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
